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Purpose: To explore the preparation and characterization of a novel nanosized magnetic 
liposome containing the PEI-As2O3/Mn0.5Zn0.5Fe2O4 complex.
Methods: Mn0.5Zn0.5Fe2O4 and As2O3/Mn0.5Zn0.5Fe2O4 nanoparticles were prepared by 
  chemical coprecipitation and loaded with PEI. The PEI- As2O3/Mn0.5Zn0.5Fe2O4 complex was 
characterized using transmission electron and scanning electron microscopy, X-ray diffraction, 
energy   dispersive spectrometry, and Fourier transform infrared spectroscopy. Cell transfection 
experiments were performed to evaluate the transfect efficiency. Magnetic nanoliposomes were 
prepared by rotatory evaporation and their shape, diameter, and thermodynamic characteristics 
were observed.
Results: Mn0.5Zn0.5Fe2O4 and PEI-As2O3/Mn0.5Zn0.5Fe2O4 nanoparticles were spherical, with an 
average diameter of 20–40 nm. PEI-As2O3/Mn0.5Zn0.5Fe2O4 was an appropriate carrier for the 
delivery of a foreign gene to HepG2 cells. Energy dispersive spectrometry results confirmed 
the presence of the elements nitrogen and arsenic. Nanoliposomes of approximately 100 nm were 
observed under a transmission electron microscope. Upon exposure to an alternating magnetic 
field, they also had good magnetic responsiveness, even though Mn0.5Zn0.5Fe2O4was modified 
by PEI and encased in liposomes. Temperatures increased to 37°C–54°C depending on different 
concentrations of PEI-As2O3/Mn0.5Zn0.5Fe2O4and remained stable thereafter.
Conclusion: Our results suggest that PEI-As2O3/Mn0.5Zn0.5Fe2O4 magnetic nanoliposomes are 
an excellent biomaterial, which has multiple benefits in tumor thermotherapy, gene therapy, 
and chemotherapy.
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Introduction
Completion of the human genome project has greatly increased the discovery of 
functional and disease-related genes. Gene therapy has become one of the most active 
research areas in biomedicine in the 21st century. One of the main advantages of gene 
therapy over traditional therapy is the potential to target the expression of therapeutic 
genes in desired cells or tissues. To achieve targeted gene expression, we developed 
a novel nonviral gene delivery system.
Arsenic trioxide (As2O3) has been adopted from traditional Chinese medicine and 
used successfully to treat refractory or relapsed acute promyelocytic leukemia.1 In 
recent years, some researchers have found that As2O3 was not only effective in leukemia 
treatment, but also effective in inhibiting several animal and human solid cancers, such 
as neuroblastoma, liver, and gastric cancers.2–4 However, there is a lack of drug speci-
ficity with the intravenous or oral administration of As2O3, resulting in the requirement International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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of large doses to achieve high local concentrations. This can 
cause nonspecific toxicity and other adverse side effects. 
Moreover, As2O3 has been generally considered to be an 
extremely effective environmental cocarcinogen for some 
human malignancies, especially for renal, skin, and lung 
cancer.5–7 Therefore, we investigated an alternative means 
of administering As2O3 to enhance its curative effects and 
reduce toxicity.
Clinically, the use of thermotherapy, such as heating 
  certain organs or tissues to temperatures between 41°C 
and 46°C, also known as hyperthermia, has been long-
used in the treatment of tumors. With the development of 
nanotechnology, magnetic nanoparticles have been used 
for tumor hyperthermia, to absorb energy from an applied 
high frequency alternating magnetic field (AMF). This 
treatment is known as magnetic fluid hyperthermia (MFH).8 
MFH is more effective in the uniform heating of deeply-
situated tumors, with relatively good targeting. Generally, in 
this technique, magnetic fluids are dispersed into the target 
tissue, which are then heated through the application of an 
external AMF.9
In this paper, we aimed to develop a novel nanosized 
magnetic liposome containing the PEI-As2O3/Mn0.5Zn0.5Fe2O4 
(PEI-As2O3/MZF) complex. Herein we also show multiple 
antitumor functions, including thermotherapy of magnetic 
MZF nanoparticles, gene therapy of PEI-modified complexes, 
and chemotherapy using As2O3. With further research, it may 
develop into a new approach for the treatment of tumors.
Experimental details
Main reagents and cell line
As2O3 (Sigma Aldrich, St Louis, MO); PEI (Sigma Aldrich); 
phosphatidyl choline (Lipoid LLC, Newark, NY); cholesterol 
(Sigma Aldrich); human liver cancer HepG2 cell lines were 
provided by the Institute of Biochemistry and Cell Biology, 
Shanghai Institute of Biological Science, Chinese Academy 
of Sciences, China.
Methods
Preparation of MZF and PeI-As2O3/ 
MZF nanoparticles
MZF nanoparticles were prepared using chemical copre-
cipitation. They were examined by transmission electron 
microscopy (TEM) (H-600; Hitachi, Tokyo, Japan) and 
scanning electron microscopy (SEM) (JSM-6360LV; Jeol, 
Tokyo, Japan). The element composition and content of the 
  nanoparticles were analyzed by X-ray diffraction (XRD) and 
energy   dispersive spectrometry (EDS) (Vantage; Thermo 
Noran, Middleton, WI). MZF was subsequently modified 
by As2O3 and adsorbed by PEI, according to a previously-
described method. The adsorption efficiency of PEI was 
demonstrated by Fourier transform infrared   spectroscopy 
(FTIR) (560; Thermo Nicolet, Madison, WI) and EDS.
cell transfection
Prior to transfection, pGFP plasmid DNA and PEI-As2O3/
MZF nanoparticles were diluted separately in serum- and 
supplement-free medium. Subsequently, 6 µg plasmid DNA 
per well was complexed with various amounts of PEI-
As2O3/MZF-NPs (10 mg/mL), corresponding to a nitrogen/
phosphorus (N/P) ratio of particles to DNA in a final 
  volume of 400 µL serum- and supplement-free medium. 
The   complexes were then incubated at room temperature 
for 30 minutes. As a reference,10 PEI (complexed with DNA 
at an N/P ratio of 7) or commercially-available transfection 
reagents, such as Lipofectamine™ (Invitrogen, Carlsbad, 
CA) were used in accordance with the manufacturer’s 
instructions.
HepG-2 cells were seeded in six well plates, at an initial 
density of 2 × 105 cells/well in 2 mL growth medium. 
After incubation for 18 hours, when cells had reached 80% 
confluency, the medium was replaced with 1.6 mL serum-free 
media and 400 µL PEI-As2O3/MZF-NPs/pGFP complexes, 
followed by a further incubation for 4 hours. The medium 
was then exchanged for fresh medium containing serum 
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Figure 1 TeM image of Mn0.5Zn0.5Fe2O4 nanoparticles.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
873
Preparation of nanocomplexes
and incubated further. Cells were observed using inverted 
fluorescence microscopy at 24 hours and 48 hours   post-
transfection, to evaluate transfection efficiency.
Preparation of nanoliposomes, containing  
PeI-As2O3/MZF and heating tests
Magnetic nanoliposomes were obtained by the combined 
methods of rotatory film and high-pressure homogenization. 
A heat test was performed to detect the thermodynamic 
characteristics of the magnetic nanoliposomes. Various 
doses of nanoliposomes were decentralized in 0.9% sodium 
chloride, with concentrations of PEI-As2O3/MZF as follows: 
5, 10, 15, 20, 30 g/L. The output electric current was 
300A and the fluid was heated for 1 hour with temperature 
measurements every 5 minutes.
Results and discussion
characterization of MZF and PeI-As2O3/
MZF nanoparticles
MZF nanoparticles were evaluated by TEM, XRD, and EDS. 
Using TEM, MZF particles appeared round or elliptical 
in shape, with good dispersion and were 20–30 nm in 
diameter (Figure 1). These nanoparticles were identified as 
Mn0.5Zn0.5Fe2O4 by XRD and EDS.
Figures 2A and 2B show PEI-As2O3/MZF nanoparticles 
under TEM and SEM. The nanoparticles were brown spheri-
cal particles, with diameters ranging from 30 to 40 nm. 
Furthermore, they suspended stably in water, with good 
diffusibility. FTIR showed specific peaks at 1,471 cm-1, 
2,826 cm-1, and 2,954 cm-1, as compared to As2O3/MZF 
complexes (Figure 3). The EDS results verified the pres-
ence of the elements manganese, zinc, iron, arsenic, and 
200 nm
AB
Figure 2 PeI-As2O3/MZF as seen by TeM (A) and seM (B).
Abbreviations: PeI, polyethyleneimine; TeM, transmission electron microscopy; 
seM, scanning electron microscopy.
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Figure 3 FTIr of PeI-As2O3/MZF: the top curve is As2O3/MZF and the bottom is PeI-As2O3/MZF.
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nitrogen (Figure 4). Further cell transfection experiments 
suggested that PEI-As2O3/MZF nanoparticles were efficient 
carriers for gene transfection. The observed green cellular 
fluorescence was due to pGFP expression, which was 
confirmed by inverted fluorescence microscopy 24 hours 
post-transfection. The expression of GFP was much clearer 
at 48 hours post-transfection (Figure 5). This high transfer 
efficiency was due to the inherent proton absorption prop-
erties of PEI.11 However, the use of PEI as a gene carrier 
is limited by   cytotoxicity and nonspecific interactions with 
serum proteins. In our study, we used nanoliposomes to 
engulf the PEI-As2O3/MZF complexes and reduce their toxic 
side effects, which has not been previously reported.
Properties of nanoliposomes containing 
PeI-As2O3/MZF
We prepared magnetic nanoliposomes containing PEI-
As2O3/MZF complexes, with an average diameter of 
approximately 100 nm. The encapsulation ratio of As2O3 
was analyzed by fluorescence spectrophotometry and 
determined to be 75.33%. An in vitro heating test was 
performed to detect the thermodynamic characteristics of 
the nanoliposomes. The temperature of the nanoliposomes 
  exposed to AMF rose rapidly within the first 5 minutes and 
slowly continued to increase from 5–40 minutes, remaining 
stable thereafter. The temperature rose from 37°C to 54°C, 
depending on various doses of PEI-As2O3/MZF (Figure 6). 
The results showed that nanoliposomes had good absorption 
properties in high-frequency alternating electromagnetic 
fields, due to the presence of magnetic nanoparticles. The 
modified PEI, As2O3, and lipid membrane did not influ-
ence the magnetic responsiveness of MZF. Therefore, 
we can select a suitable temperature range (42°C–46°C) 
for tumor hyperthermia by adjusting the concentration of 
PEI-As2O3/MZF.
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Figure 4 eDs results of PeI-As2O3/MZF.
Abbreviations: eDs, energy dispersive spectrometry.
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Figure 6 heating test result of magnetic nanoliposomes.
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Figure 5 HepG2 cells observed under fluorescence microscopy (×400) 24 hours 
after transfection (A) and 48 hours after transfection (B).International Journal of Nanomedicine
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Conclusion
Nanotechnology has been increasingly applied in the medical 
field, with potential treatments for cancer. In our study, we 
prepared a new kind of magnetic nanoliposome containing 
PEI-As2O3/MZF complexes. It has multiple antitumor 
applications, including thermotherapy using magnetic MZF 
nanoparticles, gene therapy with PEI-modified complexes, 
and chemotherapy using As2O3. In future studies, we will 
apply this novel material to tumor therapy.
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